South Korea is moving quickly to reduce what is sees as a gap in mRNA vaccine technology with major countries by forming a strategic consortium of pharma firms to speed up the development of its own COVID-19 vaccine using the platform by next year. In the coming years, the aim is to develop next generation platform technology that can be applied to other diseases.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?